VIS171

N/A

Report date: 2026/04/16 20:00:17

Base Information

Drug NameVIS171
Drug Alias NameVIS-171VIS171
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionInterleukin-2 replacements
TargetsInterleukin-2
Therapy Area/IndicationsAutoimmune DiseasesAlopecia AreataLupus Erythematosus, Systemic +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaRomaniaNetherlands +[6
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVisterra Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesAlopecia AreataLupus Erythematosus, Systemic +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A